Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus 1 or 2”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Large-scale testing (Phase 3)Ended earlyNCT00642616
What this trial is testing

Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes MellitusModerate Chronic Obstructive Pulmonary Disease+1 more
Mannkind Corporation 34
Testing effectiveness (Phase 2)Study completedNCT00406458
What this trial is testing

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy
Sangamo Therapeutics 110
Large-scale testing (Phase 3)Study completedNCT02207374
What this trial is testing

A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 601
Large-scale testing (Phase 3)Study completedNCT03770767
What this trial is testing

Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes

Who this might be right for
Diabetes MellitusPregnancy Complications
Rigshospitalet, Denmark 216
Testing effectiveness (Phase 2)UnknownNCT05333835
What this trial is testing

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 455
Not applicableStudy completedNCT00989898
What this trial is testing

Automated Overnight Closed-loop Glucose Control in Young People With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Cambridge 16
Testing effectiveness (Phase 2)Study completedNCT00320060
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 128
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07497880
What this trial is testing

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

Who this might be right for
ObesityOverweight
Kailera 320
Early research (Phase 1)Not Yet RecruitingNCT07476326
What this trial is testing

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Who this might be right for
Melanoma
Biocon Biologics UK PLC 120
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Not applicableEnded earlyNCT01079637
What this trial is testing

Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet

Who this might be right for
Diabetes Mellitus 1 or 2Midfoot Charcot Neuroarthropathy
AO Clinical Investigation and Publishing Documentation 1
Early research (Phase 1)Study completedNCT00537719
What this trial is testing

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 34
Testing effectiveness (Phase 2)Ended earlyNCT01113801
What this trial is testing

A Study in Participants With Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis
Eli Lilly and Company 417
Testing effectiveness (Phase 2)Study completedNCT04265261
What this trial is testing

Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Hoffmann-La Roche 139
Not applicableEnded earlyNCT02080741
What this trial is testing

Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Who this might be right for
Patients With Type 1 or Type 2 DiabetesPatients With a Type A or B Behaviour Profile
Centre Hospitalier Universitaire Dijon 57
Not applicableStudy completedNCT02105103
What this trial is testing

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Who this might be right for
Type 2 Diabetes, Type 1 Diabetes
Hoffmann-La Roche 80
Large-scale testing (Phase 3)Study completedNCT01336023
What this trial is testing

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,663
Not applicableUnknownNCT04383197
What this trial is testing

Exercise and GLP-1 RA on Insulin Secretion

Who this might be right for
Type 2 Diabetes
University of Copenhagen 30
Large-scale testing (Phase 3)Study completedNCT05259033
What this trial is testing

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 683
Not applicableNot Yet RecruitingNCT07420972
What this trial is testing

Pilot Study of Intrapartum Insulin Pump

Who this might be right for
DiabetesDiabetes (Insulin-requiring, Type 1 or Type 2)Pregnancy
Medstar Health Research Institute 30
Load More Results